Pier Capital, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 196 filers reported holding HERON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.4%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$7,674,000
+53.4%
326,574
+20.8%
1.26%
+48.2%
Q3 2019$5,002,000
+3.3%
270,389
+3.8%
0.85%
+13.1%
Q2 2019$4,843,000
-26.5%
260,490
-3.3%
0.75%
-26.7%
Q1 2019$6,587,000
+0.1%
269,514
+6.3%
1.02%
-21.7%
Q4 2018$6,578,000
-20.7%
253,600
-3.2%
1.30%
+24.8%
Q3 2018$8,291,000261,9701.05%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders